policy
(Photo from left: Kyong-Hoon Kim from Korea Evaluation Institute of Industrial Technology, Vice President of Research at KAIST Hee-Yoon Lee, Director Oh, Jong-Hwan Kim at the Ministry of Trade, Industry and Energy, President Ki-Han Park at the Korea Institute for Robot Industry Advancement, and Dean of KAIST Institute Yun Chol Chung.)
KAIST opened its Humanoid Robot Research Center on January 19 at the KAIST Institute. Endorsed by the Ministry of Trade, Industry and Energy with 15 billion KRW funding over five years, the center will conduct research for advancing humanoid robot technology and fostering research fellows in the field.
Professor Jun Ho Oh at the Department of Mechanical Engineering will serve as the director of the center. Team KAIST under Professor Oh won the 2015 DARPA Robotics Challenge (DRC) with its humanoid robot DRC-HUBO, beating 23 teams from six countries.
Professor Oh said, “I believe we have already achieved technological prowess through developing the HUBO robot over the past decade. The center will continue to strive for further development of original technology crucial for humanoid robots’ key components. We want to pave the way for having enough of our own technology and needing to bring in technology from abroad. Professor Oh said he will focus on fields such as high-efficiency, high-powered electric drives and hydraulic system humanoid robot capable of executing solid manipulability with high confidence and object recognition intelligence technology. In addition, he said the center will develop module type and extended open software in an effort to disseminate robot technology.
-
research Editing Parkinson's Disease – KAIST Makes World's First Discovery of an Inflammatory RNA Editing Enzyme
< Professor Minee Choi of the Department of Brain and Cognitive Sciences (top left). Professor Sonia Gandhi (top right) and Professor Klenerman of the University College London (bottom right) > Parkinson's disease (PD) is a neurodegenerative disorder in which the α-synuclein protein abnormally aggregates within brain cells, causing neuronal damage. Through international collaboration, researchers at KAIST have revealed that RNA editing plays a crucial role in regulating neuroi
2025-05-02 -
event KAIST Art Museum Showcases the Works of Van Gogh, Cy Twombly, and More at "The Vault of Masterpieces"
KAIST (President Kwang Hyung Lee) opened a special exhibition "The Vault of Masterpieces" featuring the architects of the Gallerist Hong Gyu Shin, who is active in New York, on April 29th. Since its opening in December 2024, the KAIST Museum of Art, which has mainly exhibited works from its own collection, has boldly invited internationally renowned gallerist Shin Hong-gyu to hold its first full-scale special exhibition, displaying a large number of his collections in the center of the campus
2025-04-30 -
research KAIST sends out Music and Bio-Signs of Professor Kwon Ji-yong, a.k.a. G-Dragon, into Space to Pulsate through Universe and Resonate among Stars
KAIST (President Kwang-Hyung Lee) announced on the 10th of April that it successfully promoted the world’s first ‘Space Sound Source Transmission Project’ based on media art at the KAIST Space Research Institute on April 9th through collaboration between Professor Jinjoon Lee of the Graduate School of Culture Technology, a world-renowned media artist, and the global K-Pop artist, G-Dragon. This project was proposed as part of the ‘AI Entertech Research Center’ be
2025-04-10 -
event KAIST, Galaxy Corporation Hold Signboard Ceremony for ‘AI Entertech Research Center’
KAIST (President Kwang-Hyung Lee) announced on the 9th that it will hold a signboard ceremony for the establishment of the ‘AI Entertech Research Center’ with the artificial intelligence entertech company, Galaxy Corporation (CEO Yong-ho Choi) at the main campus of KAIST. < (Galaxy Corporation, from center to the left) CEO Yongho Choi, Director Hyunjung Kim and related persons / (KAIST, from center to the right) Professor SeungSeob Lee of the Department of Mechanical Engineer
2025-04-09 -
research KAIST Identifies Master Regulator Blocking Immunotherapy, Paving the Way for a New Lung Cancer Treatment
Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to these treatments, highlighting the urgent need for new strategies tailored to both responders and non-responders. KAIST researchers have discovered that 'DEAD-box helicases 54 (DDX54)', a type of RNA-binding protein, is the master regulator that hinders the effectiveness of immunotherapy—opening
2025-04-08